Terns Pharmaceuticals (TERN)
(Delayed Data from NSDQ)
$7.53 USD
-0.65 (-7.95%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $7.68 +0.15 (1.99%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Terns Pharmaceuticals, Inc. has a market cap of $715.84M, which represents its share price of $8.18 multiplied by its outstanding shares number of 87.51M. As a small-cap company, TERN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TERN 7.53 -0.65(-7.95%)
Will TERN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TERN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TERN
Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a Turnaround
Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN)
TERN: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy
Other News for TERN
TERN forms Jack-in-the-box Bullish on September 19
Is TERN set to rally? Expansion Breakout shows up after rocketing 10.54%
Mizuho Securities Sticks to Their Buy Rating for Terns Pharmaceuticals (TERN)
Roche deal to buy 89bio boosts MASH space
Is TERN compressing before expansion? Bollinger Band Squeeze shows up after rising 1.37%